Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | EXEL | ROIV | ||
| Company | Intra-Cellular Ther | Exelixis Inc | Roivant Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 84.60 | 33.72 | 11.98 | ||
| High | 85.93 | 34.00 | 12.07 | ||
| Low | 84.41 | 33.71 | 11.88 | ||
| Last | 85.79 | 33.95 | 12.03 | ||
| Change | +0.55 | +0.13 | +0.03 | ||
| % Change | +0.65% | +0.38% | +0.25% | ||
| Volume | 86,448 | 444,899 | 1,236,992 | ||
| 20-Day Average Volume | 453,616 | 2,027,967 | 4,686,095 | ||
| Previous Close | 85.24 | 33.82 | 12.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 84.89 | 34.98 | 12.08 | ||
| 20-Day Raw Stochastic | 55.61% | 21.50% | 43.46% | ||
| 20-Day Relative Strength | 54.20% | 50.58% | 51.46% | ||
| Weighted Alpha | +24.71 | +49.48 | +9.40 | ||
| Today's Opinion | 96% Buy | 72% Buy | 80% Buy | ||
| Previous Opinion | 96% Buy | 72% Buy | 80% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.20% since 12/18/24 | +0.83% since 12/18/24 | +2.87% since 12/18/24 | ||
| Low | 82.76 on 12/20/24 | 33.11 on 12/20/24 | 11.41 on 12/20/24 | ||
| High | 87.95 on 12/19/24 | 34.15 on 12/19/24 | 12.06 on 12/26/24 | ||
| 1-Month | |||||
| %Chg | -0.87% since 11/26/24 | -6.89% since 11/26/24 | -5.31% since 11/26/24 | ||
| Low | 81.37 on 12/11/24 | 33.11 on 12/20/24 | 11.41 on 12/20/24 | ||
| High | 89.12 on 12/18/24 | 36.97 on 11/29/24 | 12.82 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | +17.03% since 09/26/24 | +29.34% since 09/26/24 | +3.93% since 09/26/24 | ||
| Low | 70.90 on 10/07/24 | 25.17 on 10/10/24 | 11.05 on 11/18/24 | ||
| High | 93.45 on 11/11/24 | 36.97 on 11/29/24 | 12.94 on 11/25/24 | ||
| 6-Month | |||||
| %Chg | +20.52% since 06/26/24 | +51.65% since 06/26/24 | +13.77% since 06/26/24 | ||
| Low | 66.26 on 07/01/24 | 21.82 on 07/03/24 | 10.00 on 08/05/24 | ||
| High | 93.45 on 11/11/24 | 36.97 on 11/29/24 | 13.06 on 09/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,036,888 | 9,658,282 | 8,735,400 | ||
| Shares Outstanding, K | 106,017 | 285,579 | 727,950 | ||
| Annual Sales | 464,370,000 | 1,830,210,000 | 124,800,000 | ||
| Annual Net Income | -139,670,000 | 207,770,000 | 4,348,930,000 | ||
| Last Quarter Sales | 175,380,000 | 539,540,000 | 4,480,000 | ||
| Last Quarter Net Income | -26,320,000 | 117,970,000 | -230,180,000 | ||
| 60-Month Beta | 0.95 | 0.52 | 1.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 10/30/24 | 0.47 on 10/29/24 | -0.29 on 11/12/24 | ||
| Latest Earnings Date | 10/30/24 | 02/04/25 | 02/11/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.74 | 0.00 | ||